Center for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington.
Department of Health Systems and Population Health, University of Washington School of Medicine, Seattle.
JAMA Netw Open. 2024 Feb 5;7(2):e2355387. doi: 10.1001/jamanetworkopen.2023.55387.
The association of COVID-19 infection with outpatient care utilization is unclear. Many studies reported population surveillance studies rather than comparing outpatient health care use between COVID-19-infected and uninfected cohorts.
To compare outpatient health care use across 6 categories of care (primary care, specialty care, surgery care, mental health, emergency care, and diagnostic and/or other care) between veterans with or without COVID-19 infection.
DESIGN, SETTING, AND PARTICIPANTS: In a retrospective cohort study of Veterans Affairs primary care patients, veterans with COVID-19 infection were matched to a cohort of uninfected veterans. Data were obtained from the Veterans Affairs Corporate Data Warehouse and the Centers for Medicare & Medicaid Services Fee-for-Service Carrier/Physician Supplier file from January 2019 through December 2022. Data analysis was performed from September 2022 to April 2023.
COVID-19 infection.
The primary outcome was the count of outpatient visits after COVID-19 infection. Negative binomial regression models compared outpatient use over a 1-year preinfection period, and peri-infection (0-30 days), intermediate (31-183 days), and long-term (184-365 days) postinfection periods.
The infected (202 803 veterans; mean [SD] age, 60.5 [16.2] years; 178 624 men [88.1%]) and uninfected (202 803 veterans; mean [SD] age, 60.4 [16.5] years; 178 624 men [88.1%]) cohorts were well matched across all covariates. Outpatient use in all categories (except surgical care) was significantly elevated during the peri-infection period for veterans with COVID-19 infection compared with the uninfected cohort, with an increase in all visits of 5.12 visits per 30 days (95% CI, 5.09-5.16 visits per 30 days), predominantly owing to primary care visits (increase of 1.86 visits per 30 days; 95% CI, 1.85-1.87 visits per 30 days). Differences in outpatient use attenuated over time but remained statistically significantly higher at 184 to 365 days after infection (increase of 0.25 visit per 30 days; 95% CI, 0.23-0.27 visit per 30 days). One-half of the increased outpatient visits were delivered via telehealth. The utilization increase was greatest for veterans aged 85 years and older (6.1 visits, 95% CI, 5.9-6.3 visits) vs those aged 20 to 44 years (4.8 visits, 95% CI, 4.7-4.8 visits) and unvaccinated veterans (4.5 visits, 95% CI, 4.3-4.6 visits) vs vaccinated veterans (3.2 visits; 95% CI, 3.4-4.8 visits).
This study found that outpatient use increased significantly in the month after infection, then attenuated but remained greater than the uninfected cohorts' use through 12 months, which suggests that there are sustained impacts of COVID-19 infection.
COVID-19 感染与门诊护理利用之间的关联尚不清楚。许多研究报告的是人群监测研究,而不是比较 COVID-19 感染患者和未感染患者队列之间的门诊医疗使用情况。
比较 COVID-19 感染和未感染退伍军人在 6 类护理(初级保健、专科保健、手术保健、心理健康、急诊和诊断和/或其他保健)之间的门诊医疗使用情况。
设计、地点和参与者:在退伍军人事务部初级保健患者的回顾性队列研究中,COVID-19 感染的退伍军人与未感染的退伍军人队列相匹配。数据来自退伍军人事务部企业数据仓库和医疗保险和医疗补助服务部按服务付费承运人/医生供应商文件,时间为 2019 年 1 月至 2022 年 12 月。数据分析于 2022 年 9 月至 2023 年 4 月进行。
COVID-19 感染。
主要结果是 COVID-19 感染后门诊就诊次数。负二项回归模型比较了感染前 1 年、感染后 0-30 天、感染后 31-183 天和感染后 184-365 天的门诊使用情况。
感染组(202803 名退伍军人;平均[标准差]年龄 60.5[16.2]岁;178624 名男性[88.1%])和未感染组(202803 名退伍军人;平均[标准差]年龄 60.4[16.5]岁;178624 名男性[88.1%])在所有协变量上匹配良好。与未感染组相比,COVID-19 感染退伍军人在感染后 0-30 天期间所有类别的门诊使用均显著升高,每 30 天增加 5.12 次就诊(95%CI,每 30 天增加 5.09-5.16 次就诊),主要是由于初级保健就诊增加(每 30 天增加 1.86 次就诊;95%CI,每 30 天增加 1.85-1.87 次就诊)。随着时间的推移,门诊使用的差异逐渐减弱,但在感染后 184-365 天仍显著高于未感染组(每 30 天增加 0.25 次就诊;95%CI,每 30 天增加 0.23-0.27 次就诊)。一半以上的增加的门诊就诊是通过远程医疗提供的。感染后门诊就诊增加最多的是 85 岁及以上的退伍军人(6.1 次就诊,95%CI,5.9-6.3 次就诊),其次是 20-44 岁的退伍军人(4.8 次就诊,95%CI,4.7-4.8 次就诊)和未接种疫苗的退伍军人(4.5 次就诊,95%CI,4.3-4.6 次就诊),而不是接种疫苗的退伍军人(3.2 次就诊;95%CI,3.4-4.8 次就诊)。
本研究发现,感染后一个月门诊就诊量显著增加,然后逐渐减弱,但仍高于未感染组 12 个月的就诊量,这表明 COVID-19 感染存在持续影响。